Abstract:The mainstay treatment for hypoxaemia is oxygen therapy, which is given to the vast majority of adults admitted to the intensive care unit (ICU). The practice of oxygen administration has been liberal, which may result in hyperoxaemia. Some studies have indicated an association between hyperoxaemia and mortality, whilst other studies have not. The ideal target for supplemental oxygen for adults admitted to the ICU is uncertain. Despite a lack of robust evidence of effectiveness, oxygen administration is widely recommended in international clinical practice guidelines. The potential benefit of supplemental oxygen must be weighed against the potentially harmful effects of hyperoxaemia. To assess the benefits and harms of higher versus lower fraction of inspired oxygen or targets of arterial oxygenation for adults admitted to the ICU. We identified trials through electronic searches of CENTRAL, MEDLINE, Embase, Science Citation Index Expanded, BIOSIS Previews, CINAHL, and LILACS. We searched for ongoing or unpublished trials in clinical trials registers. We also scanned the reference lists of included studies. We ran the searches in December 2018. We included randomized controlled trials (RCTs) that compared higher versus lower fraction of inspired oxygen or targets of arterial oxygenation for adults admitted to the ICU. We included trials irrespective of publication type, publication status, and language. We included trials with a difference between the intervention and control groups of a minimum 1 kPa in partial pressure of arterial oxygen (PaO 2 ), minimum 10% in fraction of inspired oxygen (FiO 2 ), or minimum 2% in arterial oxygen saturation of haemoglobin/non‐invasive peripheral oxygen saturation (SaO 2 /SpO 2 ). We excluded trials randomizing participants to hypoxaemia (FiO 2 below 0.21, SaO 2 /SpO 2 below 80%, and PaO 2 below 6 kPa) and to hyperbaric oxygen. Three review authors independently, and in pairs, screened the references retrieved in the literature searches and extracted data. Our primary outcomes were all‐cause mortality, the proportion of participants with one or more serious adverse events, and quality of life. None of the trials reported the proportion of participants with one or more serious adverse events according to the International Conference on Harmonisation Good Clinical Practice (ICH‐GCP) criteria. Nonetheless, most trials reported several serious adverse events. We therefore included an analysis of the effect of higher versus lower fraction of inspired oxygen, or targets using the highest reported proportion of participants with a serious adverse event in each trial. Our secondary outcomes were lung injury, acute myocardial infarction, stroke, and sepsis. None of the trials reported on lung injury as a composite outcome, however some trials reported on acute respiratory distress syndrome (ARDS) and pneumonia. We included an analysis of the effect of higher versus lower fraction of inspired oxygen or targets using the highest reported proportion of participants with ARDS or pneumonia in each trial. To assess the risk of systematic errors, we evaluated the risk of bias of the included trials. We used GRADE to assess the overall certainty of the evidence. We included 10 RCTs (1458 participants), seven of which reported relevant outcomes for this review (1285 participants). All included trials had an overall high risk of bias, whilst two trials had a low risk of bias for all domains except blinding of participants and personnel. Meta‐analysis indicated harm from higher fraction of inspired oxygen or targets as compared with lower fraction or targets of arterial oxygenation regarding mortality at the time point closest to three months (risk ratio (RR) 1.18, 95% confidence interval (CI) 1.01 to 1.37; I 2 = 0%; 4 trials; 1135 participants; very low‐certainty evidence). Meta‐analysis indicated harm from higher fraction of inspired oxygen or targets as compared with lower fraction or targets of arterial oxygenation regarding serious adverse events at the time point closest to three months (estimated highest proportion of specific serious adverse events in each trial RR 1.13, 95% CI 1.04 to 1.23; I 2 = 0%; 1234 participants; 6 trials; very low‐certainty evidence). These findings should be interpreted with caution given that they are based on very low‐certainty evidence. None of the included trials reported any data on quality of life at any time point. Meta‐analysis indicated no evidence of a difference between higher fraction of inspired oxygen or targets as compared with lower fraction or targets of arterial oxygenation on lung injury at the time point closest to three months (estimated highest reported proportion of lung injury RR 1.03, 95% CI 0.78 to 1.36; I 2 = 0%; 1167 participants; 5 trials; very low‐certainty evidence -Abstract Truncated-

The Effect of Hyperoxia on Mortality in Critically Ill Patients: a Systematic Review and Meta Analysis

Association Between Arterial Hyperoxia and Mortality in Critically Ill Patients: A Systematic Review and Meta-Analysis.

Reply to “association Between Intra-and Post-Arrest Hyperoxia on Mortality in Adults with Cardiac Arrest: A Systematic Review and Meta-Analysis”

The effect of conservative oxygen therapy in reducing mortality in critical care patients: A systematic review and meta analysis

The Effect of Conservative Oxygen Therapy in Reducing Mortality in Critical Care Patients: A Meta-Analysis and Trial Sequential Analysis

Oxygen Therapy and Ventilatory Support

The Effect of Hyperoxemia on Neurological Outcomes of Adult Patients: A Systematic Review and Meta-Analysis

Hyperoxia for sepsis and development of acute lung injury with increased mortality

Effects of Oxygenation Targets on Mortality in Critically Ill Patients in Intensive Care Units: A Systematic Review and Meta-Analysis

Arterial hyperoxia and mortality in the cardiac intensive care unit

Hyperoxia for accidental hypothermia and increased mortality: a post-hoc analysis of a multicenter prospective observational study

Harmful Effects of Hyperoxia in Postcardiac Arrest, Sepsis, Traumatic Brain Injury, or Stroke: The Importance of Individualized Oxygen Therapy in Critically Ill Patients

Harm and Management Measures of Hyperoxemia to Intensive Care Patients

Pulmonary Events in ICU patients with hyperoxia: is it possible to relate arterial partial pressure of oxygen to coded diseases? A retrospective analysis

Conservative Oxygen Therapy for Critically Ill Patients: a Meta-Analysis of Randomized Controlled Trials

Higher versus lower fraction of inspired oxygen or targets of arterial oxygenation for adults admitted to the intensive care unit.

The effect of early mobilization for critical ill patients requiring mechanical ventilation: a systematic review and meta-analysis

The interaction between arterial oxygenation and carbon dioxide and hospital mortality following out of hospital cardiac arrest: a cohort study

Association between arterial oxygen tension with clinical outcomes in patients undergoing VA-ECMO support: a systematic review and dose-response meta-analysis

Impact of Oxygen Saturation on Mortality in Obese and Non-obese Critically Ill Patients With Mechanical Ventilation: A Retrospective Observational Study

Association between arterial oxygen and mortality across critically ill patients with hematologic malignancies: results from an international collaborative network